Phase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer

Simple item page
dc.conference.dateSEP 19-OCT 18, 2020
dc.conference.titleESMO Virtual Congress
dc.contributor.authorLeary, A.
dc.contributor.authorEstevez-Garcia, P.
dc.contributor.authorSabatier, R.
dc.contributor.authorFarinas-Madrid, L.
dc.contributor.authorPerez-Fidalgo, J. A.
dc.contributor.authorRomeo, M.
dc.contributor.authorBarretina Ginesta, M. P.
dc.contributor.authorGil-Martin, M.
dc.contributor.authorGarralda, E.
dc.contributor.authorRodon, J.
dc.contributor.authorLizcano, J. M.
dc.contributor.authorMunoz Guardiola, P.
dc.contributor.authorPerez-Montoyo, H.
dc.contributor.authorYeste-Velasco, M.
dc.contributor.authorCortal, M.
dc.contributor.authorDomenech, C.
dc.contributor.authorAlfon, J.
dc.contributor.authorRay-Coquard, I. L.
dc.contributor.authorOaknin, A.
dc.contributor.authoraffiliation[Leary, A.] Inst Gustave Roussy, Med Oncol, Villejuif, France
dc.contributor.authoraffiliation[Estevez-Garcia, P.] Hosp Univ Virgen del Rocio, Med Oncol, Seville, Spain
dc.contributor.authoraffiliation[Sabatier, R.] Inst Paoli Calmettes, Med Oncol, Marseille, France
dc.contributor.authoraffiliation[Farinas-Madrid, L.] Vall dHebron, Med Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Perez-Fidalgo, J. A.] INCLIVA Hosp Clin Univ, Med Oncol, Valencia, Spain
dc.contributor.authoraffiliation[Romeo, M.] Catalan Inst Oncol IGT3, Med Oncol, Badalona, Spain
dc.contributor.authoraffiliation[Barretina Ginesta, M. P.] ICO Inst Catala Oncol Girona Hosp Univ Josep True, Dept Med Oncol, Girona, Spain
dc.contributor.authoraffiliation[Gil-Martin, M.] Inst Catala Oncol IDIBELL, Oncol, Barcelona, Spain
dc.contributor.authoraffiliation[Garralda, E.] Vall dHebron Inst Oncol VHIO, Early Drug Dev Unit UITM, Barcelona, Spain
dc.contributor.authoraffiliation[Rodon, J.] Univ Texas MD Anderson Canc Ctr, Early Drug Dev, Houston, TX 77030 USA
dc.contributor.authoraffiliation[Lizcano, J. M.] Univ Autonoma Barcelona, Inst Neurociencias, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Munoz Guardiola, P.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Perez-Montoyo, H.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Yeste-Velasco, M.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Cortal, M.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Domenech, C.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Alfon, J.] Abil Pharmaceut, Res & Dev, Cerdanyola Del Valles, Spain
dc.contributor.authoraffiliation[Ray-Coquard, I. L.] Ctr Leon Berard, Dept Med Oncol, Lyon, France
dc.contributor.authoraffiliation[Oaknin, A.] Vall dHebron Univ Hosp, Med Oncol, Barcelona, Spain
dc.contributor.funderAbility Pharmaceuticals SL
dc.date.accessioned2025-01-07T15:32:03Z
dc.date.available2025-01-07T15:32:03Z
dc.date.issued2020-09-01
dc.identifier.doi10.1016/j.annonc.2020.08.1003
dc.identifier.essn1569-8041
dc.identifier.issn0923-7534
dc.identifier.unpaywallURLhttp://www.annalsofoncology.org/article/S0923753420409998/pdf
dc.identifier.urihttps://hdl.handle.net/10668/27213
dc.identifier.wosID573469101152
dc.issue.number4
dc.journal.titleAnnals of oncology
dc.journal.titleabbreviationAnn. oncol.
dc.language.isoen
dc.organizationSAS - Hospital Universitario Virgen del Rocío
dc.page.numberS639-S640
dc.publisherElsevier
dc.rights.accessRightsopen access
dc.titlePhase II of ABTL0812, a pro-autophagic drug, in combination with paclitaxel and carboplatin (P/C) as first-line treatment in advanced/recurrent endometrial cancer
dc.typeconference output
dc.type.hasVersionVoR
dc.volume.number31
dc.wostypeMeeting Abstract

Files

Collections

SAS - Hospital Universitario Virgen del Rocío

© 2023 – Repositorio Institucional de Salud de Andalucía - Fundación Pública Andaluza Progreso y Salud - Consejería de Salud y Consumo de la Junta de Andalucía